BioSpace News Archive

Yiviva and Yale scientists will present new data from Yiviva’s oncology portfolio at the 2022 American Association for Cancer Research Annual Meeting in New Orleans on April 8-13, 2022.

Kinnate Biopharma Inc. announced that it will present data from the company’s lead RAF kinase inhibitor program, KIN-2787, and its clinico-genomics study investigating the occurrence of BRAF Class II and Class III alterations across solid tumors.

Shattuck Labs, Inc. announced preclinical data at the 2022 American Association for Cancer Research Annual Meeting.

Forward Pharma A/S, reported consolidated financial results for the year ended December 31, 2021.

Shanghai Junshi Biosciences Co., Ltd and Coherus BioSciences, Inc. announced the results of the prespecified final progression-free survival analysis and the interim overall survival analysis of the JUPITER-02 study, a pivotal Phase 3 trial in first-line treatment of recurrent or metastatic nasopharyngeal carcinoma.

Boston-area life science technology company AmberGen Inc. announced that it has closed a strategic investment by Bruker Corporation, one of the world’s leading scientific instrumentation and life-science solutions companies.

AnPac Bio-Medical Science Co., Ltd. announced that Dr. Aidong Chen has joined the Company as its board director, Chief Executive Officer and Chairman of the Board of Directors.

Hyperlipidemia or high cholesterol refers to condition that has too many lipids in the blood. Hyperlipidemia can be inherited however, unbalanced diet and little physical activity could result in hyperlipidemia.

Rise in incidences of kidney diseases and prevalence of lifestyle and chronic diseases led to adoption of different dialysis treatments.

Sumitomo Pharma Oncology, Inc. announced it will present new clinical and preclinical data on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research Annual Meeting, held April 8-13, 2022, in New Orleans, LA.